Vistin Pharma ASA Total Liabilities

Latest as of March 2026: Nkr103.25 Million NOK ≈ $10.87 Million USD

Vistin Pharma ASA total liabilities. Based on the latest financial reports, Vistin Pharma ASA (VISTN) has total liabilities worth Nkr103.25 Million NOK (≈ $10.87 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See VISTN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Vistin Pharma ASA (2016–2025)

Total liabilities of Vistin Pharma ASA from 2016 to 2025. This chart illustrates how Vistin Pharma ASA's total liabilities have evolved over time, based on quarterly financial data. Check Vistin Pharma ASA (VISTN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Vistin Pharma ASA Competitors by Total Liabilities

The table below lists competitors of Vistin Pharma ASA ranked by their total liabilities.

Company	Country	Total Liabilities
Grange Resources Ltd AU:GRR	Australia	AU$248.51 Million
Merit Turizm Yatirim ve Isletme AS IS:MERIT	Turkey	TL40.94 Million
La Kaffa International Co Ltd TWO:2732	Taiwan	NT$3.60 Billion
Hyosung Itx KO:094280	Korea	₩136.58 Billion
Yusin Holding Corp TW:4557	Taiwan	NT$2.69 Billion
Centrica PLC LSE:CNA	UK	GBX11.83 Billion
Nuveen California Select Tax Free Income Closed Fund NYSE:NXC	USA	$795.79K

Liability Composition Analysis (2016–2025)

This chart breaks down Vistin Pharma ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see VISTN total assets.

Liquidity & Leverage Metrics

Vistin Pharma ASA Total Liabilities Ratios Explained

Vistin Pharma ASA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.29	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vistin Pharma ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vistin Pharma ASA (2016–2025)

The table below shows the annual total liabilities of Vistin Pharma ASA from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	Nkr110.62 Million ≈ $11.64 Million	+46.68%
2024-12-31	Nkr75.42 Million ≈ $7.94 Million	-6.46%
2023-12-31	Nkr80.63 Million ≈ $8.48 Million	-39.81%
2022-12-31	Nkr133.95 Million ≈ $14.10 Million	+133.93%
2021-12-31	Nkr57.26 Million ≈ $6.03 Million	+15.65%
2020-12-31	Nkr49.51 Million ≈ $5.21 Million	-45.45%
2019-12-31	Nkr90.77 Million ≈ $9.55 Million	-39.97%
2018-12-31	Nkr151.21 Million ≈ $15.91 Million	+35.50%
2017-12-31	Nkr111.59 Million ≈ $11.74 Million	+20.11%
2016-12-31	Nkr92.91 Million ≈ $9.78 Million	--

About Vistin Pharma ASA

OL:VISTN Norway Drug Manufacturers - Specialty & Generic

Market Cap

$85.86 Million

Nkr815.94 Million NOK

Market Cap Rank

#19584 Global

#175 in Norway

Share Price

Nkr18.40

Change (1 day)

-1.08%

52-Week Range

Nkr18.00 - Nkr23.20

All Time High

Nkr28.06